Science Creates

Science Creates

Biotechnology Research

Science Creates is a deep tech ecosystem that enables scientists and engineers to build disruptive businesses.

About us

Science Creates believes that deep tech startups are society's most effective economic vehicle to deliver innovation and global impact for the health of people and the health of our planet. We empower, support and inspire people over three decades of their journey in becoming world leading deep tech founders. Our growing network of scientific startups are solving global problems with groundbreaking advancements in healthcare, the environment and quality of life. We have two research facilities in Bristol, a venture capital arm that offers investment into early-stage and scale-up deep tech companies, and an educational outreach charity. We and our partners support a growing cluster of deep tech startups in the UK with research facilities, a venture capital arm (SCVC) and national deep tech accelerator programmes. Our outreach charity is training the next generation of scientists and entrepreneurs, starting at age 10. The growing community is also supported by a network of carefully selected advisors and strategic partners. Since its inception, Science Creates has already incubated over 100 startups.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Bristol
Type
Privately Held
Founded
2020
Specialties
Science, Quantum Technologies , Chemistry, Startups, Scaleups, Business Incubation , Deep Tech, AI, EngBio, Biotech, Advanced Engineering, and Health Tech

Locations

  • Primary

    Science Creates - St Philips

    Albert Road

    Bristol, BS2 OXJ, GB

    Get directions
  • Science Creates - Old Market

    Midland Road

    Bristol, BS2 0NS, GB

    Get directions

Employees at Science Creates

Updates

  • View organization page for Science Creates, graphic

    5,648 followers

    Congratulations to LettUs Grow, an indoor farming technology provider, which unveiled its new Aeroponic Innovation Centre and Aeroponic Rolling Bench™ product at an exclusive opening event last week. The new site, located in Bristol, and product will enable the Science Creates member company to bring the advantages of aeroponics to the global greenhouse industry at scale by combining its world-leading ultrasonic aeroponic technology with the latest industry-standard rolling bench systems. By empowering large-scale indoor growers to increase productivity and outperform annual yield targets through aeroponics, LettUs Grow aims to deliver a sustainable solution to reduce the agricultural industry’s global environmental impact. Find out more below. #deeptech #agritech #sustainability

    View organization page for LettUs Grow, graphic

    17,555 followers

    Last week we officially opened the doors to our Aeroponic Innovation Centre in Bristol 🌿 This site marks our focus on efficient greenhouse farming, to direct aeroponic technology into facilities where it can have the greatest impact. Thank you to all our guests who joined us for the day, it was a pleasure to celebrate with you all! Watch this space for more about what we showcased at the event. #agritech #aeroponics #horticulture #sustainablefarming

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Science Creates, graphic

    5,648 followers

    Last week, we hosted the Science Creates Showcase to officially close the second round of our flagship Science Creates Engineering Biology Accelerator, and it was a fantastic celebration of Cohort 2.0's graduation from the UK Research and Innovation-funded programme. The Showcase brought investors, the Science Creates community and the national deep tech ecosystem together with Cohort 2.0 to provide the graduates with a vital platform as some of the UK’s most exciting emerging deep tech companies. We also welcomed back a number of companies from Cohort 1.0 to pitch their EngBio startups one year on from our first accelerator programme. Highlights from the Showcase include: • Harry Destecroix, Founder of Science Creates, and Francis Lister, Director of Science Creates Accelerate, kicking off the afternoon with an opening speech • 6 pitches from Cohort 2.0, showcasing their novel EngBio technologies in wastewater bioremediation, AI-powered cell therapy solutions, carbon-capture based materials production and rapid diagnostics • 7 pitches from early-stage companies from all corners of the Science Creates community, spotlighting their quantum, agritech and biotech technologies • Welcoming over 70 investors and deep tech founders from across the UK throughout the day • Closing the event with networking at the 1023 Bar in Science Creates Old Market, connecting attendees with the wider Science Creates community over cocktails Thank you to all who joined us to celebrate the end of round 2.0 of our Accelerator and the cohort's hard work to grow their ideas into living, breathing businesses over the past few months. A special thank you to all of the investors who attended, hosts from the SCVC team and the UK-wide Science Creates member companies who pitched and made the Showcase a success: PhotoClear, Deep Blue BioTechArne ScottVeronika RattajAlex WardHarry ThompsonXternaDaniele SimoneschiDelta.g, ReNewFoodPentaBindZentraxa and Transdermal Diagnostics Ltd.   #deeptech #engineeringbiology #innovation #sciencecreates

  • View organization page for Science Creates, graphic

    5,648 followers

    In the latest from the wastewater specialists at WASE - the team has announced a 3-year partnership with the University of the West of England! The Knowledge Transfer Partnership (KTP) will see WASE and the University of the West of England combine their industry expertise and research capabilities to create a machine learning-based soft sensing platform, with the aim of developing game-changing improvements to WASE’s Electro-Methanogenesis Reactor (EMR) technology. WASE, a Science Creates member company, is unlocking the power of waste to make it the fuel of the future by working with manufacturers to maximise biogas production, turning their unavoidable waste into bioenergy, water for reuse and agricultural inputs. KTP is an Innovate UK Knowledge Transfer Partnerships programme integrating academic research into companies to create a positive commercial impact, enable transformational improvements, and drive innovation. Keep reading below to find out more. #deeptech #wastewater #innovation

    View organization page for WASE, graphic

    2,633 followers

    New Partnership announcement🎉 WASE are happy to announce an exciting 3-year knowledge transfer partnership with University of the West of England funded by Innovate UK Knowledge Transfer Partnerships. The KTP offers a unique partnership between business and university aiming to drive innovation and commercial impact through collaboration. The focus of this partnership is on creating a machine learning-based soft sensing platform to be integrated within our Electro-Methanogenesis Reactor and help improve the EMR technology. This is such an amazing opportunity to develop and further the knowledge in this area. We can’t wait to see what innovative work comes from it! Read the full article here: https://lnkd.in/eeCfR2uH

    • No alternative text description for this image
  • View organization page for Science Creates, graphic

    5,648 followers

    Japan has joined the list of countries Imophoron Ltd has patented its novel ADDomer™ platform in a major update from the specialist biopharmaceutical company. The granting of this patent means that Imophoron Ltd has now secured patents in the three largest pharmaceutical markets, the US, Europe and Japan, giving the startup a strong, global exclusivity position which enhances its team's ability to lead the development of thermostable vaccines. Congratulations! Imophoron Ltd, a Science Creates member company, has created novel vaccines based on the ADDomer™ platform to provide the world with next-generation therapeutics for unmet medical needs and future threats. ADDomer™ is a patented technology for creating highly immunogenic vaccine candidates and is a multimeric protein-based, self-assembling nanoparticle scaffold. Find out more below. #deeptech #biotech #healthcare #startups

    View organization page for Imophoron Ltd, graphic

    1,645 followers

    We’re thrilled to announce the grant of a pivotal patent by the Japan Patent Office for our ADDomer™ platform, marking a major milestone in our mission to advance thermostable nanoparticle vaccines. This exclusive patent strengthens our IP portfolio, extending protection until 2037 and reinforcing our position in global markets.   With patents secured in the US, Europe, and now Japan, Imophoron Ltd is well-positioned to continue developing groundbreaking vaccines for viral infections and other urgent healthcare needs. 🔗 For more details, visit our website: www.imophoron.com

  • View organization page for Science Creates, graphic

    5,648 followers

    We're excited to see that QLM Technology Ltd is progressing its collaborative research into quantum gas detection after securing funding from Innovate UK and the Department for Environment, Food and Rural Affairs. This support comes as part of a wider three-year £13.6 million innovation in environmental monitoring programme which funds projects aimed at advancing monitoring capabilities in strategically significant areas. Under this programme, QLM Technology Ltd—a photonics technology and analytics company—will conduct the NUTMEG project, focusing on developing, constructing and testing a portable greenhouse gas sensor for environmental monitoring applications. Their project joins 18 other collaborative projects which will inform decision-making to enhance environmental resilience, protect natural resources and contribute to a sustainable future in the UK. Find out more below. #deeptech #quantumtech #environmentalmonitoring

    View organization page for QLM Technology Ltd, graphic

    2,219 followers

    QLM is proud to announce the continuation of our research collaboration in gas detection exploiting 2nd generation quantum technology. Innovate UK and Department for Environment, Food and Rural Affairs (DEFRA) are supporting our research under the Environmental Monitoring Innovation fund. The “Nonlinear Upconversion Technique for Monitoring Environmental Gases” (NUTMEG) project builds upon our previous research collaboration with Covesion Ltd., Fraunhofer Centre for Applied Photonics and University of Bristol on the ‘UP-SENSE’ project. This approach uses photonic up-conversion single-photon spectroscopy for gas sensing.  Optical waveguides in non-linear materials developed by Covesion enable the quantum process of up-conversion of photons from short-wave infra-red (SWIR) to visible wavelengths, facilitating detecting light with efficient single-photon avalanche detectors, whilst interrogating for the presence of gas at more sensitive SWIR wavelengths. The NUTMEG project will develop, construct and test a portable greenhouse gas sensor for environmental monitoring applications. Working with Covesion and Fraunhofer, we will demonstrate a platform approach targeting CO2, Methane, NOx and Ammonia monitoring. https://lnkd.in/et96q4BC #photonics #quantum #environmentalmonitoring #emissionsreduction

    £6m for 19 innovation projects to monitor environmental change

    £6m for 19 innovation projects to monitor environmental change

    ukri.org

  • View organization page for Science Creates, graphic

    5,648 followers

    Carbon dioxide removal (CDR) needs bold innovators to accelerate global efforts to mitigate climate change - that's why neo-fossil, an engineering biology start-up at Science Creates, is engineering cells to store atmospheric CO2 for centuries. The neo-fossil team's innovative approach to CDR has secured them a spot in cohort 7 of remove's Europe Accelerator, the premier European program that accelerates startups addressing CDR solutions to deliver climate impact. This two-staged 6-month accelerator program will see neo-fossil supported through their entrepreneurial journey with specialist coaching, non-dilutive funding and access to a global CDR community to progress their CDR technology. Keep reading below to find out more and to discover the rest of the cohort. #deeptech #innovation #climatetech #startups

    View organization page for remove, graphic

    5,137 followers

    🚀 Announcing Cohort 7 of our Europe CDR Startup #Accelerator Program 🚀 We are thrilled to kick-off the latest cohort of remove's Foundations program and onboard a new set of promising Europe-based CDR #startups! These teams are raising the bar every cohort. The quality of applications we received over the last couple of months is a testament to the fact that this industry is maturing and we are excited to be supporting the key actors driving #carbon removal forward. After careful consideration in a competitive process, our jury of experts selected 20 teams to join us on this journey. 👏 Congratulations to: SuperDAC (Silvia Pugliese), Bloomineral, Residual (Ted Christie-Miller & Laura Fritsch), Porelio, Artio, X-SAF (Benjamin Schulz), Kumo, UAP | Atmosphere Engineering, Bluelotus.solutions, biodiversityX, neo-fossil, Atmosfuture Limited, OXO Earth, Deep Blue BioTech, Bigfoot, Nina.Energy, AEROC, B3ET, Pyrogen, BCHAR on their selection! We are looking forward to working with this new and exciting group of startups, supporting them with training, 1-on-1 coaching, connections to experts, buyers, investors, other #CDR ecosystem stakeholders, non-dilutive #funding and more. remove is the premier accelerator program focused solely on CDR in Europe and India and we are supported by incredible founding partners: The Grantham Foundation for the Protection of the Environment, Carbon Removal Partners, and The DOEN Foundation.

    • No alternative text description for this image
  • View organization page for Science Creates, graphic

    5,648 followers

    Isomab Ltd has announced its first antibody therapeutic, ISM-001, as a Development Candidate for peripheral arterial disease (PAD), alongside a strategic collaboration with global biopharmaceutical company, Pfizer Ignite! Working to develop isoform-specific antibodies to treat serious and life-threatening diseases, these milestones will allow Isomab Ltd, a biotech start-up and Science Creates member company, to advance ISM-001 into pre-clinical studies as a potential first-in-class treatment candidate for PAD. With PAD affecting 230 million people worldwide, the progression of Isomab Ltd's innovations could improve millions of lives across the globe. Find out more below. #deeptech #innovation #biotech

    View organization page for Isomab Ltd, graphic

    559 followers

    📣 NEW PRESS RELEASE: IsomAb Announces Nomination of Development Candidate for Peripheral Arterial Disease and Strategic Collaboration with Pfizer    We’re delighted to share that we have nominated ISM-001 as a development candidate for peripheral arterial disease (PAD). ISM-001 is a potential first-in-class, therapeutic antibody designed to neutralise VEGF-A165b, the anti-angiogenic VEGF-A splice isoform which acts as a brake on development of new blood vessels leading to chronic limb threatening ischaemia (CLTI). ISM-001 is being advanced into a program of pre-clinical studies necessary for gaining approval to enter first-in-human clinical trials.   We’re also excited to announce a strategic collaboration with Pfizer Ignite to accelerate preclinical and IND-enabling studies for ISM-001.    Our CEO, Jackie Turnbull, said: “Today’s announcement represents an important milestone for IsomAb and we continue to be encouraged by the potential of ISM-001 as a first-in-class treatment for patients with PAD, especially type 2 diabetics with CTLI at high risk of amputation. We appreciate the devastating loss of losing a limb and the impact on the lives of patients who have very limited treatment options. Given Pfizer’s strong commitment, extensive capabilities and deep expertise in developing new therapeutics, we are proud to partner with them to support the development of ISM-001, a transformative treatment for patients with PAD. We look forward to realising the full potential of ISM-001.” Read the full release: https://lnkd.in/grUzYW-y

    • No alternative text description for this image
  • View organization page for Science Creates, graphic

    5,648 followers

    Extracellular is now ISO 22000 certified! Extracellular is a development partner dedicated to supporting cultivated meat and seafood companies, and this ISO 22000 certification validates the team's commitment to global standards of quality assurance, manufacturing and business. Working to scale research, development and manufacturing capabilities for sustainable biotech, this is a key step in Extracellular's journey as the first-choice manufacturing partner for the future bioeconomy. Congratulations! #deeptech #innovation #biotech #sustainability

    View organization page for Extracellular, graphic

    4,668 followers

    🎉 We're now ISO 22000 Certified!! 🎉 👷♀️ We've been working hard behind the scenes at Extracellular to implement world-class, internationally recognised quality standards within our facilities and operations, adding to the ISO 9001 we achieved earlier this year 👷♀️ 🏆 This a huge milestone for us to be able to produce safe, high-quality and nutritious alternative food products for our customers 🏆 🏭 It aligns perfectly with the commencement of production operations from our pilot-scale facility, meaning we'll be able to produce bio-produced food for a range of development and commercial purposes globally - reach out if you're in need! 🏭 And of course, a big kudos to all the Quality & Operations team at Extracellular, led by Jamie Thompson, for all the hard-work over the months

  • View organization page for Science Creates, graphic

    5,648 followers

    📣 Deep Tech founders & startup leaders: We have exciting news. Plans to open OMX, our new Deep Tech incubator in central Bristol, are swiftly coming together for a late 2025 launch. OMX will offer state-of-the-art R&D space for growing startups working in quantum and biotech. As well as the essential lab and office space needed to grow your Deep Tech venture, you'll join a strong community of impact-driven startups on a shared mission: improving the health of people and the planet through groundbreaking innovations. Interested? Let's start a conversation 👉 https://lnkd.in/eXcPgGu6 Harry Destecroix Ashley Brewer Patrick Page Fallon Francis Lister University of Bristol Research England #deeptech #innovation #startups #bristol #sciencecreates

  • View organization page for Science Creates, graphic

    5,648 followers

    Could glucose-responsive insulin (GRI) be the answer to transforming diabetes care for hundreds of millions of people worldwide? Carbometrics has collaborated with leading global healthcare company Novo Nordisk to conduct cutting-edge research into GRIs—a type of smart insulin that responds dynamically to varying glucose levels in blood—and their potential for revolutionising diabetes treatment, and the findings were published in today's Nature paper (Nature Magazine): https://lnkd.in/eF5vbKkX Carbometrics is a biotech startup developing the world’s most selective synthetic Glucose Binding Molecule (GBM) to support reliable and accurate diabetes management. It was spun-out from Ziylo following Ziylo's acquisition by Novo Nordisk in 2018 to accelerate the healthcare leader's development of GRIs - Ziylo was founded by Harry Destecroix, who went on to found Science Creates. As a Science Creates member company and SCVC portfolio company, Carbometrics specialises in the design, synthesis, and derivatisation of highly selective and robust synthetic Glucose Binding Molecules. Find out more about their novel tech here: https://lnkd.in/exnvPA8m It's great to see the work this team is doing to empower millions to improve their lifestyles. #deeptech #biotech #diabetescare #innovation

    View organization page for Carbometrics, graphic

    886 followers

    We are delighted to unveil our latest groundbreaking research on glucose-responsive insulins (GRIs), in collaboration with Novo Nordisk and University of Bristol, as featured in Nature. This study marks a major advancement in Carbometrics’ mission to transform diabetes care. 📑💡 Our team's efforts have led to the development of 'smart' insulins capable of dynamically responding to changes in blood glucose levels. This innovation could ultimately lead to a safer and more effective approach to insulin therapy, potentially revolutionising how diabetes is managed worldwide. 🌍🩺 Thank you to Novo Nordisk and our dedicated team for their commitment to advancing healthcare solutions. We look forward to further reducing the burden on people living with diabetes and shaping the future of diabetes treatment. 🚀💙 Join us in celebrating this milestone achievement! Follow the links below to learn more about our research and its impact on diabetes care: Glucose-Sensitive Insulin — Carbometrics: https://lnkd.in/exnvPA8m Smart insulin switches itself off in response to low blood sugar — Nature News & Views: https://lnkd.in/eupNzW7P Glucose-sensitive insulin with attenuation of hypoglycaemia — Nature article: https://lnkd.in/eF5vbKkX #Healthcare #Diabetes #Insulin #GRI #Type1Diabetes #T1D #NovoNordisk #Carbometrics #Bristol #Research

    • No alternative text description for this image

Similar pages

Browse jobs

Funding

Science Creates 1 total round

Last Round

Grant

US$ 10.7M

See more info on crunchbase